Physician profile
John L Andrew
NPI 1033171335
$1,096.55
in general payments reported to CMS, 2019-2025
9 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $133 · 2021: $33.55 · 2022: $164 · 2023: $135 · 2024: $237 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $606.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $602.20 | 2022-2025 | Penumbra System, Indigo System, Red 72 |
| Medtronic USA, INC. | $184.72 | 2019-2020 | |
| Inari Medical, INC. | $83.57 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $77.42 | 2021-2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Stryker Corporation | $69.07 | 2020 | |
| Astellas Pharma US INC | $22.91 | 2019 | |
| Medtronic, INC. | $20.99 | 2023 | Osteocool Rf Ablation System |
| Argon Medical Devices, INC. | $20.12 | 2023 | Tips |
| Siemens Medical Solutions USA, INC. | $15.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Andrew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.